Summary
Ketoprofen (KT), a 2-arylpropionic acid nonsteroidal antiinflammatory drug, is administered as a racemate. Previous reports suggest stereoselective biliary excretion of KT enantiomers. This hypothesis was tested by administering 50 mg racemic KT to five patients who required bile drainage following cholecystectomy surgery. Subsequently, to study the influence of probenecid (PB), an inhibitor of KT renal elimination, on the biliary excretion, 1000 mg PB was administered 1.5 h before KT to the same patients. The unchanged and conjugated (as glucuronides) KT enantiomers were measured in plasma, urine and bile.
In general, KT enantiomers had different plasma concentration-time curves. As compared to normal subjects, these patients had comparable AUCs and shorter t1/2s. Biliary concentrations of conjugated S-KT were greater than R-KT. Nevertheless, the total cumulative biliary excretion of conjugated KT did not exceed 2% of the dose ruling out this pathway as a significant route of KT elimination.
There was a positive and significant correlation between the cumulative urinary excretion of conjugated KT enantiomers and creatinine clearance. Although PB did not influence the pattern of stereoselectivity of KT, it increased AUC and prolonged t1/2 of the enantiomers. While reducing cumulative urinary excretion, PB increased total biliary elimination of conjugated KT enantiomers. This, however, did not totally compensate for the reduced urinary excretion.
It is suggested that the impaired conjugation of KT caused by PB administration may result in the augmentation of other, otherwise minor, metabolic pathways.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Baber N, Halliday L, Sibeon R, Littler T, Orme ML'E (1978) The interaction between indomethacin and probenecid. Clin Pharmacol Ther 24: 298–307
Duggan DE, Hooke KF, White SD, Noll RM, Stevenson CR (1977) The effects of probenecid upon the individual components of indomethacin elimination. J Pharmacol Exp Ther 201: 463–470
Fleck C, Braunlich H (1984) Methods in testing interrelationships between excretion of drugs via urine and bile. Pharmacol Ther 25: 1–22
Foster RT, Jamali F, Russell AS, Alballa SR (1988a) Pharmacokinetics of ketoprofen enantiomers in healthy subjects following single and multiple doses. J Pharm Sci 77: 70–73
Foster RT, Jamali F, Russell AS, Alballa SR (1988b) Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. J Pharm Sci 77: 191–195
Foster RT, Jamali F (1987) High performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine. J Chromatogr 416: 388–393
Foster RT, Jamali F (1988) Stereoselective pharmacokinetics of ketoprofen in the rat: Influence of route of administration. Drug Metab Disp 16: 623–626
Harnoss BM, Harnoss CM, Borner K, Lode H, Koeppe P (1985) Biliary elimination of apalcillin in cholecystectomized patients. Chemotherapy 31: 266–271
Meffin PJ, Zilm DM, Veenendaal JR (1983) A renal mechanism for the clofibric acid-probenecid interaction. J Pharmacol Exp Ther 227: 739–742
Mehvar R, Jamali F (1988) Pharmacokinetic analysis of the enantiomeric inversion of chiral nonsteroidal antiinflammatory drugs. Pharm Res 5: 76–79
Melethil S, Conway WD (1976) Urinary excretion of probenecid and its metabolites in humans as a function of dose. J Pharm Sci 65: 861–865
Mills RFN, Adams SS, Cliffe EE, Dickinson W, Nicholson JS (1973) The metabolism of ibuprofen. Xenobiotica 3: 589–598
Pentikainen PJ, Tokola O, Alhava E, Penttila A (1984) Pharmacokinetics of tolfenamic acid: disposition in bile, blood and urine after intravenous administration to man. Eur J Clin Pharmacol 27: 349–354
Populaire P, Terlain B, Pascal S, Decouvelaere B, Renard A, Thomas J-P (1973) Comportement biologique: taux seriques, excretion et biotransformation de l'acide (benzoyl-3 phenyl)-2 propionique ou ketoprofene chez l'animal et chez l'homme. Ann Pharm Franc 31: 735–749
Rollins DE, Klaassen CD (1979) Biliary excretion of drugs in man. Clin Pharmacokinet 4: 368–379
Rubin A, Knadler MP, Ho PK, Bechtol LD, Wolen RL (1985) Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans. J Pharm Sci 74: 82–84
Rundle FF, Cass MH, Robson B, Middleton M (1955) Bile drainage after choledochostomy in man, with some observations on biliary fistula. Surgery 37: 903–910
Runkel R, Mroszczak E; Chaplin M, Sevelius H, Segre E (1978) Naproxen-probenecid interaction. Clin Pharmacol Ther 24: 706–713
Smith PC, Langendijk PNJ, Bosso JA, Benet LZ (1985) Effect of probenecid on the formation and elimination of acyl glucuronides: Studies with zomepirac. Clin Pharmacol Ther 38: 121–127
Sorgel F, Beyhl FE, Mutschler E (1980) Inhibition of uridinediphosphate glucuronyltransferase caused by furosemide. Experientia 36: 861–863
Terhaag B, Hermann U (1986) Biliary elimination of indomethacin in man. Eur J Clin Pharmacol 29: 691–695
Upton RA, Buskin JN, Williams RL, Holford NHG, Riegelman S (1980) Negligible excretion of unchanged ketoprofen, naproxen and probenecid in urine. J Pharm Sci 69: 1254–1257
Upton RA, Williams RL, Buskin JN, Jones RM (1982) Effects of probenecid on ketoprofen kinetics. Clin Pharmacol Ther 31: 705–712
Veenendaal JR, Brooks PM, Meffin PJN (1981) Probenecid-clofibrate interaction. Clin Pharmacol Ther 29: 351–358
Verbeeck RK, Dickinson RG, Pond SM (1989) Biliary excretion of diflunisal conjugates in patients with T-tube drainage. Eur J Clin Pharmacol (in press)
Verbeeck RK, Wallace SM, Loewen GR (1984) Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation. Br J Clin Pharmac 17: 783–784
Yesair DW, Remington L, Callahan M, Kensler CJ (1970) Comparative effects of salicylic acid, phenylbutazone, probenecid and other anions on the metabolism, distribution and excretion of indomethacin by rats. Bioch Pharm 19: 1591–1600
Yu T-F, Perel J (1980) Pharmacokinetic and clinical studies of carprofen in gout. J Clin Pharmacol 20: 347–351
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foster, R.T., Jamali, F. & Russell, A.S. Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid. Eur J Clin Pharmacol 37, 589–594 (1989). https://doi.org/10.1007/BF00562550
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00562550